Amgen Inc (AMGN)
334.71
+0.41
(+0.12%)
USD |
NASDAQ |
Jul 26, 16:00
335.15
+0.44
(+0.13%)
After-Hours: 20:00
Amgen Price: 334.71 for July 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 25, 2024 | 335.99 | 346.85 | 333.02 | 334.30 | 2.394M |
| Jul 24, 2024 | 333.25 | 337.18 | 330.34 | 335.61 | 2.459M |
| Jul 23, 2024 | 334.36 | 337.04 | 331.31 | 333.24 | 1.458M |
| Jul 22, 2024 | 333.23 | 337.09 | 332.47 | 335.97 | 1.734M |
| Jul 19, 2024 | 333.65 | 333.98 | 328.43 | 331.29 | 1.849M |
| Jul 18, 2024 | 334.20 | 338.98 | 330.67 | 330.97 | 2.228M |
| Jul 17, 2024 | 330.00 | 336.61 | 328.60 | 335.67 | 1.933M |
| Jul 16, 2024 | 330.46 | 335.91 | 328.00 | 333.14 | 1.879M |
| Jul 15, 2024 | 331.88 | 332.81 | 327.87 | 330.15 | 1.689M |
| Jul 12, 2024 | 327.82 | 333.85 | 326.01 | 330.83 | 2.191M |
| Jul 11, 2024 | 322.00 | 327.99 | 320.18 | 325.09 | 2.254M |
| Jul 10, 2024 | 317.06 | 322.88 | 314.64 | 321.67 | 2.192M |
| Jul 09, 2024 | 311.62 | 316.08 | 307.63 | 315.91 | 1.853M |
| Jul 08, 2024 | 311.36 | 315.48 | 310.61 | 311.46 | 1.167M |
| Jul 05, 2024 | 311.03 | 313.41 | 308.57 | 310.88 | 1.274M |
| Jul 03, 2024 | 311.49 | 312.54 | 306.11 | 309.38 | 1.001M |
| Jul 02, 2024 | 310.25 | 312.43 | 307.64 | 310.77 | 1.543M |
| Jul 01, 2024 | 313.34 | 319.00 | 310.23 | 311.01 | 1.769M |
| Jun 28, 2024 | 313.70 | 316.68 | 310.59 | 312.45 | 3.518M |
| Jun 27, 2024 | 311.73 | 316.79 | 310.72 | 313.69 | 2.082M |
| Jun 26, 2024 | 317.18 | 317.48 | 311.72 | 312.82 | 2.800M |
| Jun 25, 2024 | 319.23 | 326.12 | 318.40 | 319.31 | 3.428M |
| Jun 24, 2024 | 310.00 | 318.34 | 307.92 | 318.15 | 3.389M |
| Jun 21, 2024 | 313.13 | 313.44 | 307.29 | 308.16 | 6.933M |
| Jun 20, 2024 | 304.83 | 310.30 | 303.55 | 309.89 | 2.890M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
176.08
Minimum
Jul 29 2019
335.97
Maximum
Jul 22 2024
243.76
Average
240.10
Median
Price Benchmarks
| Eli Lilly and Co | 805.11 |
| Merck & Co Inc | 125.31 |
| Pfizer Inc | 30.78 |
| AbbVie Inc | 185.15 |
| Viking Therapeutics Inc | 65.87 |
Price Related Metrics
| PE Ratio | 47.82 |
| PS Ratio | 6.089 |
| Price to Book Value | 35.75 |
| Price to Free Cash Flow | 25.33 |
| Earnings Yield | 2.09% |
| Market Cap | 179.55B |
| Operating PE Ratio | 25.81 |
| Normalized PE Ratio | 47.82 |